T, W., AR, P., AG, K., H, Y., L, Z., DT, S., . . . EP, P. (2021). Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets. Cell stem cell, 28(6), 1074. https://doi.org/10.1016/j.stem.2021.01.011
Chicago Style (17th ed.) CitationT, Wang, Pine AR, Kotini AG, Yuan H, Zamparo L, Starczynowski DT, Leslie C, and Papapetrou EP. "Sequential CRISPR Gene Editing in Human IPSCs Charts the Clonal Evolution of Myeloid Leukemia and Identifies Early Disease Targets." Cell Stem Cell 28, no. 6 (2021): 1074. https://doi.org/10.1016/j.stem.2021.01.011.
MLA (9th ed.) CitationT, Wang, et al. "Sequential CRISPR Gene Editing in Human IPSCs Charts the Clonal Evolution of Myeloid Leukemia and Identifies Early Disease Targets." Cell Stem Cell, vol. 28, no. 6, 2021, p. 1074, https://doi.org/10.1016/j.stem.2021.01.011.